A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease

NCT00229736 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

GENETIC: AAV-hAADC-2
GENETIC: AAV-hAADC-2

Sponsor

Genzyme, a Sanofi Company